Exit

About KonTEM Exit

Sample analysis in structural biology often suffers from weak contrast in the transmission electron microscope (TEM). The KonTEM PhazR solves this contrast problem and thus enables scientists to extract more information about structure and function of cells on molecular level.

Exit since May 2014. Purchaser: FEI Company (NASDAQ: FEIC)

Press releases

Press
22. May 2014

Profitable exit: KonTEM trade sale to FEI Company (NASDAQ: FEIC)

KonTEM GmbH, an HTGF-financed spin-off of the Max Planck Society and the research centre caesar, was taken over by FEI Company on a share deal basis. Thus the phase contrast technology developed by KonTEM is absorbed in the portfolio of a globally operating market leader in the field of high-performance microscopy workflow solutions. The phase contrast system for transmission electron microscopy (TEM) developed by KonTEM enables a two to three times better image contrast without compromising
 
Press
17. April 2012

High-Tech Gründerfonds invests in KonTEM GmbH

Joint press release of High-Tech Gründerfonds, Max-Planck-Innovation GmbH, Center of advanced european studies and research (caesar) and KonTEM GmbH. KonTEM GmbH, a spin-off company of the Max-Planck-Gesellschaft (MPG) and the Center of advanced european studies and research (caesar), has developed an innovative phase contrast system for transmission electron microscopes (TEM). The system combines enhanced image contrast with high object resolution and thus opens up new possibilities for the
 

Info & Contact

Phone:
+49 228 180 33 200
Web:
www.kontem.de

Address

Ludwig-Erhard-Allee 2
53175 Bonn

In portfolio

04. Apr 2012 – 02. May 2014
 

Dr. Andreas Olmes

Principal / Authorized Signatory
Exit